查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631560

女性健康体检市场规模、份额、趋势分析报告（按应用、最终用途和地区划分），2025 年至 2030 年

Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application (Cancer, Infectious Disease, Osteoporosis), By End Use (Hospitals, Laboratory, Home Care), By Region, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

女性健康体检市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，到 2030 年全球女性健康诊断市场规模预计将达到 314.6 亿美元。

预计 2025 年至 2030 年期间市场复合年增长率为 7.29%。照护现场的采用率不断提高以及各种慢性病和文明病的盛行率不断上升是推动市场成长的关键因素。此外，预计在预测期内各种宣传计划的推出也将有利于市场。例如，2014年欧盟委员会发起了「欧洲提高综合癌症控製品质指南」联合倡议。

随着各机构资金投入的增加，妇女健康检查呈现高速成长。例如，2015 年 5 月，Abcodia 获得了 Cambridge Innovative Capital、Scottish Equity Partners 和 Albion Ventures 的资金，用于在英国推出卵巢癌风险演算法 (ROCA) 测试，以早期发现卵巢癌。的来自 UCLB 的资助。

根据最终用途，市场分为医院和诊断中心以及家庭用途。由于医院就诊次数较多且检测更可靠，医院和诊断中心占据了市场的大部分份额。

未来几年亚太市场可能会大幅成长。市场的成长归因于医疗保健投资的增加、国际设备製造商专注于加强其在该地区的销售业务，以及该地区从感染疾病转变为慢性病的流行病学日益增多。向

女性健康检查市场报告重点

  • 政府和私人实体的投资增加以及可支配收入的提高正在推动市场的发展。
  • 2024年，癌症将占据最大的市场占有率。由于早期检测测试的普及和政府对抗癌症的倡议，该领域在预测期内将实现显着增长。
  • 由于产前疾病盛行率上升、母亲年龄增加、医疗保健支出快速增长以及先进诊断测试的发展，产前检测估计将成为这段时期成长最快的领域。
  • 按地区划分，北美将占据市场主导地位，到 2024 年将占据最大的收益占有率，达到 46.21%。由于诊断和成像中心的基础不断扩大、癌症患者数量不断增加、人们对不孕症检测认识的不断提高以及就地检验设备的广泛使用，预计到 2030 年它将保持主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章女性健康筛检变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 女性健康检查分析工具
    • 产业分析-波特五力分析
    • PESTEL 分析

4. 女性健康诊断市场：細項分析，按应用，2018 - 2030 年（百万美元）

  • 定义和范围
  • 2024 年和 2030 年应用市场占有率分析
  • 女性健康体检市场（按应用划分），2018 至 2030 年
  • 2018 年至 2030 年市场规模、预测与趋势分析

5. 女性健康诊断市场：細項分析，依最终用途，2018 - 2030 年（百万美元）

  • 定义和范围
  • 2024 年及 2030 年最终用途市场占有率分析
  • 2018 年至 2030 年全球女性健康诊断市场（依最终用途划分）
  • 2018 年至 2030 年市场规模、预测与趋势分析

第六章：女性健康体检市场：区域估计与趋势分析

  • 区域控制面板
  • 市场规模、预测趋势分析，2018-2030 年：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的近期趋势及影响分析
  • 2024 年公司市场占有率分析
  • 主要企业简介
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Quest Diagnostics Incorporated
    • Abbott
    • BD
    • GE Healthcare
    • Koninklijke Philips NV
    • Aspira Women's Health
    • Thermo Fisher Scientific Inc.
    • Cardinal Health, Inc.
Product Code: GVR-2-68038-581-6

Women's Health Diagnostics Market Growth & Trends:

The global women's health diagnostics market size is expected to reach USD 31.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.29% from 2025 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights:

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2024. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America dominated the market and accounted for the largest revenue share of 46.21% in 2024. It is anticipated to maintain its dominance through 2030, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Women's Health Diagnostics Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of various health conditions in women
      • 3.2.1.2. Growing women health awareness,
      • 3.2.1.3. Technological advancements in diagnostics equipment
      • 3.2.1.4. Aging women population
      • 3.2.1.5. Developing global healthcare infrastructure
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of access of diagnostic solutions
      • 3.2.2.2. High cost of diagnostic solutions
  • 3.3. Women's Health Diagnostics Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Women's Health Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Application Market Share Analysis, 2024 & 2030
  • 4.3. Women's Health Diagnostics Market, by Application, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Cancer
      • 4.4.1.1. Cancer market, 2018 - 2030 (USD Million)
    • 4.4.2. Infectious diseases
      • 4.4.2.1. Infectious diseases market, 2018 - 2030 (USD Million)
    • 4.4.3. Osteoporosis
      • 4.4.3.1. Osteoporosis market, 2018 - 2030 (USD Million)
    • 4.4.4. Pregnancy & fertility
      • 4.4.4.1. Pregnancy & fertility market, 2018 - 2030 (USD Million)
    • 4.4.5. Prenatal
      • 4.4.5.1. Prenatal market, 2018 - 2030 (USD Million)

Chapter 5. Women's Health Diagnostics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2024 & 2030
  • 5.3. Global Women's Health Diagnostics Market, by End Use, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Hospitals
      • 5.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
    • 5.4.2. Laboratory
      • 5.4.2.1. Laboratory market, 2018 - 2030 (USD Million)
    • 5.4.3. Home care
      • 5.4.3.1. Home care market, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Women's Health Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. China
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. South Africa
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Kuwait
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. F. Hoffmann-La Roche Ltd.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Hologic, Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Quest Diagnostics Incorporated
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Abbott
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. BD
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. GE Healthcare
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Koninklijke Philips N.V.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Aspira Women's Health
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Thermo Fisher Scientific Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Cardinal Health, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 6. U.S. women's health diagnostics, by application, 2018 - 2030 (USD Million)
  • Table 7. U.S. women's health diagnostics, by end use, 2018 - 2030 (USD Million)
  • Table 8. Canada women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 9. Canada women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Mexico women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11. Mexico women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Europe women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 13. Europe women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14. Europe women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 15. UK women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 16. UK women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Germany women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18. Germany women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19. France women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 20. France women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 21. Italy women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 22. Italy women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Spain women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24. Spain women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Norway women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 26. Norway women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Sweden women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28. Sweden women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Denmark women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 30. Denmark women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Asia Pacific women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34. China women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 35. China women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Japan women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 37. Japan women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 38. India women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39. India women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 40. Australia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 41. Australia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 42. South Korea women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 43. South Korea women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Thailand women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 45. Thailand women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Latin America women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 47. Latin America women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48. Latin America women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Brazil women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 50. Brazil women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Argentina women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52. Argentina women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Colombia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 54. Colombia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa women's health diagnostics, by bag usage, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 58. South Africa women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 59. South Africa women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62. UAE women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 63. UAE women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65. Kuwait women's health diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Women's health diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Women's health diagnostics market: Application movement analysis
  • Fig. 18 Women's health diagnostics market application outlook: Key takeaways
  • Fig. 19 Cancer market, 2018 - 2030 (USD Million)
  • Fig. 20 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 21 Osteoporosis market, 2018 - 2030 (USD Million)
  • Fig. 22 Pregnancy & fertility market, 2018 - 2030 (USD Million)
  • Fig. 23 Prenatal market, 2018 - 2030 (USD Million)
  • Fig. 24 Women's health diagnostics market: End Use movement analysis
  • Fig. 25 Women's health diagnostics market end use outlook: Key takeaways
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Laboratory market, 2018 - 2030 (USD Million)
  • Fig. 28 Home care market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional outlook, 2019 & 2027
  • Fig. 31 Regional market place: Key takeaways
  • Fig. 32 North America, SWOT, by PEST
  • Fig. 33 Europe, SWOT, by PEST
  • Fig. 34 Asia Pacific, SWOT, by PEST
  • Fig. 35 Latin America, SWOT, by PEST
  • Fig. 36 Middle East and Africa,, SWOT, by PEST
  • Fig. 37 North America women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 38 US women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 42 UK women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 France women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 52 China women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 53 India women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 60 MEA women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait women's health diagnostics market, 2018 - 2030 (USD Million)